Yeh tell that to the 10 million dollars they have that will take them through to phase 2 and because the drug works in vitro, pre clinical and phase 1 ticked off we will have a multi billion dollar drug on our hands in the coming years. Big period ahead and with pre clinical ticked off, in vitro ticked off and the last 4 years of drug development I’m very comfortable with the road ahead. Should be a 70-100 million dollar valuation on potential
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-77
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
